Growth Metrics

RemSleep Holdings (RMSL) EBT Growth (3y) (2013 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -2.47%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 7.77%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.70%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 37.81%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 4.82%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 32.11%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 61.06%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -2.57%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 14.40%
10 RemSleep Holdings - - -7,636.00 7.11%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 7.11%
Sep 30, 2025 -94.93%
Jun 30, 2025 13.22%
Mar 31, 2025 35.34%
Dec 31, 2024 -26.68%
Sep 30, 2024 30.62%
Jun 30, 2024 54.30%
Mar 31, 2024 18.78%
Dec 31, 2023 -16.49%
Sep 30, 2023 0.13%
Jun 30, 2023 -97.87%
Mar 31, 2023 6.13%
Dec 31, 2022 21.77%
Sep 30, 2022 -59.35%
Jun 30, 2022 42.75%
Mar 31, 2022 18.84%
Dec 31, 2021 -33.70%
Sep 30, 2021 -33.61%
Jun 30, 2021 -97.33%
Mar 31, 2021 -42.74%
Dec 31, 2020 -98.39%
Sep 30, 2020 -35.12%
Jun 30, 2020 28.78%
Mar 31, 2020 -16.59%
Dec 31, 2019 -72.58%
Sep 30, 2019 -584.07%
Jun 30, 2019 -798.99%
Mar 31, 2019 -182.45%
Dec 31, 2018 218.70%
Sep 30, 2018 -1,049.03%
Jun 30, 2018 -99.72%
Mar 31, 2018 -68.05%
Dec 31, 2017 26.10%
Sep 30, 2017 -91.40%
Jun 30, 2017 -148.45%
Mar 31, 2017 -115.87%
Dec 31, 2016 7.57%
Sep 30, 2016 89.00%
Jun 30, 2016 84.03%
Mar 31, 2016 49.70%
Dec 31, 2015 62.90%
Sep 30, 2015 92.12%
Jun 30, 2015 61.06%
Mar 31, 2015 -25.57%
Dec 31, 2014 -110.84%
Jun 30, 2014 32.18%
Mar 31, 2014 46.18%
Dec 31, 2013 87.60%
Sep 30, 2013 18.29%